Description
Palmityl Palmitate Catalog B2017938 (50 mg)
| Catalog | B2017938 |
| Lot | Batch dependent |
| Expiration | Batch dependent |
| Amount | 50 mg |
| Molecular Weight | 480.85 g/mol |
| Supplied As | Powder |
| Applications | Molecular tool for biochemical and immunological applications |
| Storage | 28 C |
| Keywords | Cetyl palmitate, Hexadecyl hexadecanoate, Palmitic acid palmityl ester |
| Grade | Biotechnology grade; all solutions made with Type I ultrapure water (resistivity>18 Mcm) and filtered through 0.22 m |
High-purity wax ester for biochemical modeling and lipid assay development. Palmityl Palmitate (Catalog B2017938, 50 mg) is a biotechnology-grade wax ester composed of palmitic acid and palmityl alcohol. This highly pure powder is designed as a versatile molecular tool for biochemical and immunological research. Its well-defined molecular weight (480.85 g/mol) and stable form make it suitable for enzymatic studies, lipid-protein interaction assays, and model membrane systems.
This compound is especially useful in exploring lipid metabolism, surfactant preparation, and ester-linked biochemical reactions. Its purity and preparation under biotech-grade standardsusing ultrapure water and filtrationensure reproducibility across experiments and minimize background noise in sensitive assays. Researchers studying lipid signaling, fatty acid derivatives, or biophysical modeling rely on Palmityl Palmitate as a reference compound and as a reagent for constructing lipid delivery or stabilization systems.
Supplied as a powder and stored at 28 C, it offers convenience and long-term stability. Bulk supply options are available to support scaling for high-throughput and longitudinal studies. As with all products from this line, it is strictly for Research Use Only (RUO) and not intended for clinical or therapeutic use.
Why researchers choose this product:
- Wax ester derivative (palmitic acid + palmityl alcohol) with defined molecular weight
- High-purity, biotechnology-grade preparation ensures reproducibility
- Stable powder format supports dosing flexibility and extended shelf life
- Applicable in lipid metabolism, enzyme assays, and biophysical research
- Available in bulk quantities to support scaling and continuity
Indication for Use:
This product is for Research Use Only (RUO). It is not intended for diagnostic, therapeutic, or clinical applications.
References:
- 1: Mol PA, Oscai LB, Holloszy JO. Adaptation of muscle to exercise. Increase in levels of palmityl Coa synthetase, carnitine palmityltransferase, and palmityl Coa dehydrogenase, and in the capacity to oxidize fatty acids J Clin Invest. 1971 Nov;50(11):2323-30.
- 2: Bremer J, Norum KR. Palmityl-CoA: carnitine O-palmityltransferase in the mitochondrial oxidation of palmityl-CoA Eur J Biochem. 1967 Jun;1(4):427-33.
- 3: Coupland CE, Andrei SA, Ansell TB, Carrique L, Kumar P, Sefer L, Schwab RA, Byrne EFX, Pardon E, Steyaert J, Magee AI, Lanyon-Hogg T, Sansom MSP, Tate EW, Siebold C. Structure, mechanism, and inhibition of Hedgehog acyltransferase Mol Cell. 2021 Dec 16;81(24):5025-5038.e10.
- 4: Wititsuwannakul D, Kim KH. Mechanism of palmityl coenzyme A inhibition of liver glycogen synthase J Biol Chem. 1977 Nov 10;252(21):7812-7.
- 5: Bank WJ, DiMauro S, Bonilla E, Capuzzi DM, Rowland LP. A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase N Engl J Med. 1975 Feb 27;292(9):443-9.
- 6: Lee C, Choi JS, Kim I, Byeon HJ, Kim TH, Oh KT, Lee ES, Lee KC, Youn YS. Decanoic acid-modified glycol chitosan hydrogels containing tightly adsorbed palmityl-acylated exendin-4 as a long-acting sustained-release anti-diabetic system Acta Biomater. 2014 Feb;10(2):812-20.
- 7: SENIOR JR, ISSELBACHER KJ. Formation of higher glycerides from monopalmitin and palmityl-CoA by microsomes of rat intestinal mucosa Biochem Biophys Res Commun. 1961 Nov 29;6:274-8.
- 8: Bremer J, Norum KR. The mechanism of substrate inhibition of palmityl coenzyme A:carnitine palmityltransferase by palmityl coenzyme A J Biol Chem. 1967 Apr 25;242(8):1744-8.
- 9: Stults JT, Griffin PR, Lesikar DD, Naidu A, Moffat B, Benson BJ. Lung surfactant protein SP-C from human, bovine, and canine sources contains palmityl cysteine thioester linkages Am J Physiol. 1991 Aug;261(2 Pt 1):L118-25.
- 10: Knobling A, Schiffmann D, Sickinger HD, Schweizer E. Malonyl and palmityl transferase-less mutants of the yeast fatty-acid-synthetase complex Eur J Biochem. 1975 Aug 15;56(2):359-67.
